Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neuropharmacology

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.neuropharm.2013.10.034PMID 24225197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors.

  2013cited by this paper
• Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy?

  2013cited by this paper
• Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain.

  2013cited by this paper
• The Microglial α7-Acetylcholine Nicotinic Receptor Is a Key Element in Promoting Neuroprotection by Inducing Heme Oxygenase-1 via Nuclear Factor Erythroid-2-Related Factor 2

  2013cited by this paper
• Systemic administration of an alpha-7 nicotinic acetylcholine agonist reverses neuropathic pain in male Sprague Dawley rats.

  2012cited by this paper
• Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin.

  2012cited by this paper
• Type I and II positive allosteric modulators differentially modulate agonist‐induced up‐regulation of α7 nicotinic acetylcholine receptors

  2012cited by this paper
• The α7 nicotinic acetylcholine receptor complex: one, two or multiple drug targets?

  2012cited by this paper
• Minocycline and fluorocitrate suppress spinal nociceptive signaling in intrathecal IL‐1β–induced thermal hyperalgesic rats

  2012cited by this paper
• Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.

  2012cited by this paper
• The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia.

  2012cited by this paper
• Novel Small Molecule &agr;9&agr;10 Nicotinic Receptor Antagonist Prevents and Reverses Chemotherapy-Evoked Neuropathic Pain in Rats

  2012cited by this paper
• Analgesic and Antineuropathic Drugs Acting Through Central Cholinergic Mechanisms

  2011cited by this paper
• Interventions for preventing neuropathy caused by cisplatin and related compounds.

  2011cited by this paper
• Cytokine-Induced Alterations of α7 Nicotinic Receptor in Colonic CD4 T Cells Mediate Dichotomous Response to Nicotine in Murine Models of Th1/Th17- versus Th2-Mediated Colitis

  2011cited by this paper
• Functional and structural imaging of pain-induced neuroplasticity

  2011cited by this paper
• Design, Synthesis, and Pharmacological Characterization of Novel Spirocyclic Quinuclidinyl‐Δ2‐Isoxazoline Derivatives as Potent and Selective Agonists of α7 Nicotinic Acetylcholine Receptors

  2011cited by this paper
• Expression of the α7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS.

  2011cited by this paper
• Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases.

  2010cited by this paper
• Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of α7 nicotinic receptors and internalization of NMDA receptors

  2010cited by this paper
• Repeated administration of α7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases α7 nAChR levels in the brain

  2010cited by this paper
• Protective effect of alpha7 nAChR: Behavioural and morphological features on neuropathy

  2010cited by this paper
• Neuroprotective effects of acetyl‐L‐carnitine on neuropathic pain and apoptosis: A role for the nicotinic receptor

  2009cited by this paper
• Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF‐H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF‐H as a potential ALS biomarker

  2009cited by this paper
• Therapy of chemotherapy‐induced peripheral neuropathy

  2009cited by this paper
• Pathological and protective roles of glia in chronic pain

  2009cited by this paper
• Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction.

  2009cited by this paper
• A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain

  2009cited by this paper
• Evaluation of α7 Nicotinic Acetylcholine Receptor Agonists and Positive Allosteric Modulators Using the Parallel Oocyte Electrophysiology Test Station

  2009cited by this paper
• Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug Discovery

  2009cited by this paper
• Oxaliplatin‐induced neuropathy in the rat: Involvement of oxalate in cold hyperalgesia but not mechanical allodynia

  2009cited by this paper
• Comparative analysis of the time-dependent functional and molecular changes in spinal cord degeneration induced by the G93A SOD1 gene mutation and by mechanical compression

  2008cited by this paper
• Nicotinic receptor subtypes in rat subfornical organ neurons and glial cells.

  2008cited by this paper
• Assembly and trafficking of nicotinic acetylcholine receptors (Review)

  2008cited by this paper
• Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.

  2008cited by this paper
• Targeting the cholinergic system as a therapeutic strategy for the treatment of pain.

  2007cited by this paper
• Neurologic complications of chemotherapy agents

  2007cited by this paper
• Targeting the α9α10 nicotinic acetylcholine receptor to treat severe pain

  2007cited by this paper
• Protective effect of acetyl‐l‐carnitine on the apoptotic pathway of peripheral neuropathy

  2007cited by this paper
• Targeting the alpha9alpha10 nicotinic acetylcholine receptor to treat severe pain.

  2007cited by this paper
• Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems.

  2007cited by this paper
• Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin

  2007cited by this paper
• Toll-Like Receptor Signaling Is Critical for Wallerian Degeneration and Functional Recovery after Peripheral Nerve Injury

  2007cited by this paper
• The innate immunity of the central nervous system in chronic pain: The role of Toll-like receptors

  2007cited by this paper
• The neuropathic pain triad: neurons, immune cells and glia

  2007cited by this paper
• Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms

  2006cited by this paper
• Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role

  2006cited by this paper
• The pathophysiology of traumatic brain injury in alpha7 nicotinic cholinergic receptor knockout mice.

  2006cited by this paper
• Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists.

  2006cited by this paper
• The Selective α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide Hydrochloride] Enhances GABAergic Synaptic Activity in Brain Slices and Restores Auditory Gating Deficits in Anesthetized Rats

  2005cited by this paper
• The vagus nerve and the nicotinic anti-inflammatory pathway

  2005cited by this paper
• Role of the Immune system in chronic pain

  2005cited by this paper
• The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.

  2005cited by this paper
• Autonomic neural regulation of immunity

  2005cited by this paper
• Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.

  2005cited by this paper
• Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss.

  2005cited by this paper
• Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury.

  2005cited by this paper
• Carbofuran induces apoptosis of rat cortical neurons and down-regulates surface alpha7 subunit of acetylcholine receptors.

  2004cited by this paper
• The effects of cisplatin on rat spinal ganglia: a study by light and electron microscopy and by morphometry

  2004cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004cited by this paper
• Regulation of nicotinic receptor expression by the ubiquitin–proteasome system

  2004cited by this paper
• The α7 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against β-amyloid1–42 toxicity in primary neuron-enriched cultures

  2004cited by this paper
• Nicotinic Receptors Differentially Regulate N-Methyl-d-aspartate Damage in Acute Hippocampal Slices

  2003cited by this paper
• Inflammation: A nervous connection

  2003cited by this paper
• The lymphocytic cholinergic system and its contribution to the regulation of immune activity.

  2003cited by this paper
• Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

  2003cited by this paper
• The vagus nerve, macrophages, and nicotine.

  2003cited by this paper
• Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats

  2003cited by this paper
• Loss of nicotinic acetylcholine receptor subunits alpha4 and alpha7 in the cerebral cortex of Parkinson patients.

  2003cited by this paper
• Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients

  2003cited by this paper
• Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries

  2002cited by this paper
• The inflammatory reflex

  2002cited by this paper
• Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation

  2002cited by this paper
• Acute oxaliplatin-induced peripheral nerve hyperexcitability.

  2002cited by this paper
• Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.

  2002cited by this paper
• Relationship between the increased cell surface α7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists

  2001cited by this paper
• Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.

  2001cited by this paper
• Mind over immunity

  2001cited by this paper
• Traumatic Brain Injury Reduces Hippocampal α7 Nicotinic Cholinergic Receptor Binding

  2000cited by this paper
• Cellular Expression of α7 Nicotinic Acetylcholine Receptor Protein in the Temporal Cortex in Alzheimer's and Parkinson's Disease— A Stereological Approach

  2000cited by this paper
• Loss of muscarinic antinociception by antisense inhibition of M1 receptors

  2000cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• Decreased Protein Levels of Nicotinic Receptor Subunits in the Hippocampus and Temporal Cortex of Patients with Alzheimer’s Disease

  2000cited by this paper
• Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain.

  1999cited by this paper
• From the gate to the neuromatrix.

  1999cited by this paper
• Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model.

  1998cited by this paper
• Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.

  1998cited by this paper
• Calibration of methods for determining numbers of dorsal root ganglion cells.

  1990cited by this paper
• The paradox of nicotinic acetylcholine receptor upregulation by nicotine.

  1990cited by this paper
• Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons.

  1990cited by this paper
• κ‐Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat

  1988cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• Conopeptides as Modulators of Pain and Inflammation in Chemotherapy-Induced Peripheral Neuropathy by Targeting α7 and α9 Nicotinic Acetylcholine Receptors

  2026cites this paper
• Innate immunity in chemotherapy-induced peripheral neuropathy: recent advances

  2025cites this paper
• α7nAChR-mediated astrocytic activation: a novel mechanism of Xiongzhi Dilong decoction in ameliorating chronic migraine.

  2024cites this paper
• Centralizing the Knowledge and Interpretation of Pain in Chemotherapy-Induced Peripheral Neuropathy: A Paradigm Shift towards Brain-Centric Approaches

  2024cites this paper
• New Insight into Neuropathic Pain: The Relationship between α7nAChR, Ferroptosis, and Neuroinflammation

  2024cites this paper
• Biological Mediators and Partial Regulatory Mechanisms on Neuropathic Pain Associated With Chemotherapeutic Agents.

  2024cites this paper
• The Role of Alpha-7 Nicotinic Acetylcholine Receptors in Pain: Potential Therapeutic Implications

  2024cites this paper
• α7 Nicotinic acetylcholine receptor potentiation downregulates chemotherapy-induced inflammatory overactivation by overlapping intracellular mechanisms.

  2023cites this paper
• DRG Explant Model: Elucidating Mechanisms of Oxaliplatin-Induced Peripheral Neuropathy and Identifying Potential Therapeutic Targets

  2023cites this paper
• Anti-Hyperalgesic Efficacy of Acetyl L-Carnitine (ALCAR) Against Visceral Pain Induced by Colitis: Involvement of Glia in the Enteric and Central Nervous System

  2023cites this paper
• Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies

  2023cites this paper
• Targeting α7-nAChR by galantamine mitigates reserpine-induced fibromyalgia-like symptoms in rats: Involvement of cAMP/PKA, PI3K/AKT, and M1/M2 microglia polarization.

  2023cites this paper
• The Antinociceptive Activity of (E)-3-(thiophen-2-yl)-N-(p-tolyl)acrylamide in Mice Is Reduced by (E)-3-(furan-2-yl)-N-methyl-N-(p-tolyl)acrylamide Through Opposing Modulatory Mechanisms at the α7 Nicotinic Acetylcholine Receptor

  2023cites this paper
• Nicotinic acetylcholine receptors: Therapeutic targets for novel ligands to treat pain and inflammation

  2023cites this paper
• Efficacy of a vegetal mixture composed of Zingiber officinale, Echinacea purpurea, and Centella asiatica in a mouse model of neuroinflammation: In vivo and ex vivo analysis

  2022cites this paper
• Targeting α7 nicotinic acetylcholine receptors for chronic pain

  2022cites this paper
• EVALUATION OF THE EFFICIENCY OF ALPHA-LIPOIC ACID AND IPIDACRINE HYDROCHLORIDE FOR THE PREVENTION OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY ACCORDING TO THE TOTAL NEUROPATHY SCORE.

  2022cites this paper
• Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy

  2021cites this paper
• The Mechanisms Mediated by α7 Acetylcholine Nicotinic Receptors May Contribute to Peripheral Nerve Regeneration

  2021cites this paper
• Antioxidant support to ameliorate the oxaliplatin-dependent microglial alteration: Morphological and molecular study

  2021cites this paper
• Toxic Effect of Platinum Compounds: Molecular Mechanisms of Toxicity

  2021cites this paper
• Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development

  2021cites this paper
• Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues

  2021cites this paper
• The Antagonism of the Prokineticin System Counteracts Bortezomib Induced Side Effects: Focus on Mood Alterations

  2021cites this paper
• Pain Relieving and Neuroprotective Effects of Non-opioid Compound, DDD-028, in the Rat Model of Paclitaxel-Induced Neuropathy

  2021cites this paper
• Stable desensitization of α7 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site.

  2021cites this paper
• The Spinal α7-Nicotinic Acetylcholine Receptor Contributes to the Maintenance of Cancer-Induced Bone Pain

  2021cites this paper
• Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence

  2021cites this paper
• Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy

  2021cites this paper
• The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms.

  2020cites this paper
• ICH3, a selective alpha7 nicotinic acetylcholine receptor agonist, modulates adipocyte inflammation associated with obesity

  2020cites this paper
• Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy

  2020cites this paper
• Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors.

  2020cites this paper
• Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment

  2020cites this paper
• The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity

  2020cites this paper
• Critical Residue Properties for Potency and Selectivity of α-Conotoxin RgIA Towards α9α10 Nicotinic Acetylcholine Receptors.

  2020cites this paper
• Chemotherapy‐induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design

  2020cites this paper
• ROLE OF 7-CHLORO-4-(PHENYLSELANYL) QUINOLINE IN THE TREATMENT OF OXALIPLATIN-INDUCED HEPATIC TOXICITY IN MICE.

  2020cites this paper
• Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation.

  2020cites this paper
• Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation

  2020cites this paper
• Behavioral Pharmacology of the Cholinergic System

  2020cites this paper
• Oxaliplatin-induced haematological toxicity and splenomegaly in mice

  2020cites this paper
• The Role of Satellite Glial Cells, Astrocytes, and Microglia in Oxaliplatin-Induced Neuropathic Pain

  2020influential citation
• (E)-3-Furan-2-yl-N-p-tolyl-acrylamide and its Derivative DM489 Decrease Neuropathic Pain in Mice Predominantly by α7 Nicotinic Acetylcholine Receptor Potentiation.

  2020cites this paper
• Effects mediated by the α7 nicotinic acetylcholine receptor on cell proliferation and migration in rat adipose-derived stem cells

  2020cites this paper
• Targeting strategies for chemotherapy-induced peripheral neuropathy: does gut microbiota play a role?

  2019cites this paper
• N-aryl-N'-ureido-O-sulfamates: Potent and selective inhibitors of the human Carbonic Anhydrase VII isoform with neuropathic pain relieving properties.

  2019cites this paper
• The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal.

  2019influential citation
• Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity.

  2019cites this paper
• Effect of α7nAChR on learning and memory dysfunction in a rat model of diffuse axonal injury.

  2019cites this paper
• Choline attenuates inflammatory hyperalgesia activating nitric oxide/cGMP/ATP-sensitive potassium channels pathway.

  2019cites this paper
• RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats

  2019cites this paper
• Neoline is the active ingredient of processed aconite root against murine peripheral neuropathic pain model, and its pharmacokinetics in rats.

  2019cites this paper
• Eliciting α7‐nAChR exerts cardioprotective effects on ischemic cardiomyopathy via activation of AMPK signalling

  2019cites this paper
• In vivo and in vitro ADMET profiling and in vivo pharmacodynamic investigations of a selective &agr;7 nicotinic acetylcholine receptor agonist with a spirocyclic &Dgr;2‐isoxazoline molecular skeleton

  2018cites this paper
• Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation.

  2018cites this paper
• Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidence

  2018cites this paper
• Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway.

  2018cites this paper
• Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects.

  2018cites this paper
• New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs

  2018cites this paper
• Nicotinic Acetylcholine Receptor Signaling in Neuroprotection

  2018cites this paper
• Transcriptome analysis of dorsal root ganglia's diabetic neuropathy reveals mechanisms involved in pain and regeneration

  2018cites this paper
• Regulation by Nicotinic Acetylcholine Receptors of Microglial Glutamate Transporters: Role of Microglia in Neuroprotection

  2018cites this paper
• Involvement of the N/OFQ‐NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad?

  2018cites this paper
• Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine‐Δ2‐Isoxazoline Scaffold: Synthesis and Electrophysiological Evaluation

  2017cites this paper
• Platinum-induced neurotoxicity: A review of possible mechanisms

  2017cites this paper
• The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator‐activated receptor‐&agr; represents a new antinociceptive signaling pathway in mice

  2017cites this paper
• Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy.

  2017cites this paper
• Neurorestoration from medicinal plants: an opportunity to treat painful neuropathies

  2017cites this paper
• Inhibitory Effects of Valproic Acid in Oxaliplatin-Induced Neuropathy in Rat Model

  2017cites this paper
• Arctic A&bgr;40 blocks the nicotine‐induced neuroprotective effect of CHRNA7 by inhibiting the ERK1/2 pathway in human neuroblastoma cells

  2017cites this paper
• Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglion.

  2016cites this paper
• Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy.

  2016cites this paper
• Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.

  2016cites this paper
• The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.

  2016cites this paper
• Immunomodulatory effects of nicotine on interleukin 1β activated human astrocytes and the role of cyclooxygenase 2 in the underlying mechanism

  2016cites this paper
• Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: relevance of nicotinic receptors

  2016cites this paper
• Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats

  2015cites this paper
• Effect of Prolonged Moderate Exercise on the Changes of Nonneuronal Cells in Early Myocardial Infarction

  2015cites this paper
• Delay of Morphine Tolerance by Palmitoylethanolamide

  2015cites this paper
• Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization.

  2015cites this paper
• Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?

  2015cites this paper
• Delay of Morphine Tolerance by Palmitoylethanolamide Lorenzo Di

  2015cites this paper
• Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection.

  2015cites this paper
• α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity

  2015cites this paper
• &agr;‐Conotoxin RgIA protects against the development of nerve injury‐induced chronic pain and prevents both neuronal and glial derangement

  2014cites this paper
• Glial role in oxaliplatin-induced neuropathic pain.

  2014cites this paper
• Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARγ Agonism as Preventive Pharmacological Approach

  2014cites this paper